Capstone Investment Advisors, LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Capstone Investment Advisors, LLC

  • $29.5 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$72.61 - $90.2 $377,572 - $469,040
-5,200 Reduced 55.32%
4,200 $368,000
Q3 2020

Nov 16, 2020
BUY
$71.87 - $131.03 $402,472 - $733,768
5,600 Added 147.37%
9,400 $715,000
Q2 2020

Aug 14, 2020
BUY
$79.55 - $124.22 $302,290 - $472,036
3,800 New
3,800 $469,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email